Novel benzoyl thioureido benzene sulfonamides as highly potent and selective inhibitors of carbonic anhydrase IX: optimization and bioactive studies
- 9 November 2018
- journal article
- research article
- Published by Royal Society of Chemistry (RSC) in MedChemComm
- Vol. 9 (12) , 2100-2105
Abstract
Novel benzoyl thioureido benzene sulfonamides as CA IX inhibitors such as 6a displayed inhibitory activity against CA IX with an IC 50 value of 0.48 nM and about 1500-fold selectivity over CA II were reported.Keywords
This publication has 35 references indexed in Scilit:
- Carbonic anhydrase inhibitorsBioorganic & Medicinal Chemistry Letters, 2010
- Hypoxia and cancerJournal of Molecular Medicine, 2007
- Carbonic Anhydrase Inhibitors. The Mitochondrial Isozyme VB as a New Target for Sulfonamide and Sulfamate InhibitorsJournal of Medicinal Chemistry, 2005
- Carbonic anhydrase inhibitors: Design of thioureido sulfonamides with potent isozyme II and XII inhibitory properties and intraocular pressure lowering activity in a rabbit model of glaucomaBioorganic & Medicinal Chemistry Letters, 2005
- Carbonic anhydrase inhibitors: synthesis and inhibition of cytosolic/tumor-associated carbonic anhydrase isozymes I, II, and IX with sulfonamides incorporating 1,2,4-triazine moietiesBioorganic & Medicinal Chemistry Letters, 2004
- Hypoxia activates the capacity of tumor‐associated carbonic anhydrase IX to acidify extracellular pHFEBS Letters, 2004
- Expression of vascular endothelial growth factor, hypoxia inducible factor 1α, and carbonic anhydrase IX in human tumoursJournal of Clinical Pathology, 2004
- Review ArticleJournal of Enzyme Inhibition and Medicinal Chemistry, 2004
- Hypoxia — a key regulatory factor in tumour growthNature Reviews Cancer, 2002
- Effects of dichlorophenamide, zinc, and manganese on otolith development in miceDevelopmental Biology, 1972